These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7836783)

  • 61. Use of bovine conglutinin for the assay of immune complexes.
    Eisenberg RA; Theofilopoulos AN; Dixon FJ
    J Immunol; 1977 Apr; 118(4):1428-34. PubMed ID: 850071
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 63. Assessment of reticuloendothelial system function in man using receptor-specific probes.
    Hamburger MI
    Neth J Med; 1984; 27(9):359-67. PubMed ID: 6239984
    [No Abstract]   [Full Text] [Related]  

  • 64. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera.
    Svensson B
    Scand J Rheumatol Suppl; 1980; 31():21-7. PubMed ID: 6992265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis.
    Weyand C
    Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Significance of antinuclear anti-histone antibodies].
    Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G
    Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
    Horgan C; Taylor RP
    Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Retroviruses and autoimmune rheumatic diseases.
    Kalden JR; Gay S
    Clin Exp Immunol; 1994 Oct; 98(1):1-5. PubMed ID: 7923867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
    Elkon KB; Lanham JG; Dash AC; Hughes GR
    Clin Exp Immunol; 1981 Aug; 45(2):279-82. PubMed ID: 6976243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for intracellular complement-fixing complexes of IgG rheumatoid factor in rheumatoid plasma cells.
    Natvig JB; Munthe E; Pahle J
    Rheumatology; 1975; 6():167-76. PubMed ID: 128108
    [No Abstract]   [Full Text] [Related]  

  • 76. The place of cyclosporine A in the treatment of connective tissue diseases.
    Miescher PA; Favre H; Mihatsch MJ; Chatelanat F; Huang YP; Zubler R
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):224-37. PubMed ID: 3381275
    [No Abstract]   [Full Text] [Related]  

  • 77. Technique-related variation in results of FANA tests.
    Chaiamnuay P; Johnston C; Maier J; Russell AS
    Ann Rheum Dis; 1984 Oct; 43(5):755-7. PubMed ID: 6388514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences in the metabolism of C4 isotypes in patients with complement activation.
    Peake PW; Pussell BA; Charlesworth JA; Gavrilovic L; Timmermans V
    Clin Exp Immunol; 1989 Oct; 78(1):49-53. PubMed ID: 2530015
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups.
    Thorsteinsson L; Abrahamsen TG; Frøland SS; Kåss OE
    Scand J Rheumatol; 1981; 10(1):49-54. PubMed ID: 6971489
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epidermal IgG deposits in patients with chronic inflammatory connective tissue diseases: diagnostic value and correlation to clinical and immunological parameters in patients with primary Sjögren's syndrome.
    Oxholm P; Oxholm A; Manthorpe R
    Clin Exp Rheumatol; 1987; 5(1):5-9. PubMed ID: 3594964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.